Encompass Health Corporation (EHC) To Go Ex-Dividend on April 1st

Encompass Health Corporation (NYSE:EHC) declared a quarterly dividend on Thursday, February 19th. Shareholders of record on Wednesday, April 1st will be given a dividend of 0.19 per share on Wednesday, April 15th. This represents a c) annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, April 1st.

Encompass Health has decreased its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 2 years. Encompass Health has a dividend payout ratio of 13.6% meaning its dividend is sufficiently covered by earnings. Research analysts expect Encompass Health to earn $5.28 per share next year, which means the company should continue to be able to cover its $0.76 annual dividend with an expected future payout ratio of 14.4%.

Encompass Health Trading Up 0.2%

Shares of EHC opened at $97.73 on Monday. The company’s fifty day simple moving average is $102.57 and its 200-day simple moving average is $111.11. The company has a market cap of $9.72 billion, a P/E ratio of 17.64, a P/E/G ratio of 1.87 and a beta of 0.71. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. Encompass Health has a twelve month low of $92.77 and a twelve month high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The firm’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period in the previous year, the company earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, analysts expect that Encompass Health will post 4.8 EPS for the current year.

Insider Transactions at Encompass Health

In related news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares in the company, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Encompass Health

Several institutional investors have recently made changes to their positions in EHC. Hsbc Holdings PLC increased its position in Encompass Health by 412.7% during the 4th quarter. Hsbc Holdings PLC now owns 276,194 shares of the company’s stock valued at $29,606,000 after purchasing an additional 222,327 shares during the period. Rockefeller Capital Management L.P. boosted its stake in shares of Encompass Health by 81.9% during the fourth quarter. Rockefeller Capital Management L.P. now owns 3,568 shares of the company’s stock valued at $379,000 after purchasing an additional 1,606 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Encompass Health by 109.6% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 761 shares of the company’s stock valued at $81,000 after buying an additional 398 shares during the period. MidFirst Bank bought a new position in Encompass Health in the fourth quarter worth approximately $202,000. Finally, Virtu Financial LLC purchased a new stake in Encompass Health during the fourth quarter worth $371,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.